Notify me when Vaddi Krishna files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | Common Stock, par value $0.0001 per share | 13% | $19,562,376 | +$1,008,643 | 6,745,647 | +5.4% | Vaddi Krishna | 31 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|